Brief: Singular Genomics Partners With Agilent To Enable The SureSelect Target Enrichment Reagents For The G4 Sequencing Platform
28/02/2022 12:47
Feb 28 (Reuters) - Singular Genomics Systems Inc OMIC.O :
* SINGULAR GENOMICS PARTNERS WITH AGILENT TO ENABLE THE
SURESELECT
TARGET ENRICHMENT REAGENTS FOR THE G4 SEQUENCING PLATFORM
Source text for Eikon: ID:nGNX8wMjZv
Further company coverage: OMIC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Singular Genomics Systems
See all newsBrief: Singular Genomics Systems Inc Deerfield Increases Purchase Price To $24.00 Per Share
Brief: Singular Genomics Receives Non-Binding Acquisition Proposal From Concentra Biosciences And Tang Capital
Singular Genomics up after Tang Capital offers to buy it
Brief: Tang Capital Management, Llc Reports 14.9% Stake In Singular Genomics Systems Inc As Of Sept 16 - SEC Filing
Brief: Singular Genomics Receives Non-Binding Acquisition Proposal From Deerfield